Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155869 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of Depot NTX in Homeless Veterans
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT01155869 is a Phase 4 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 7 participants.
The verdict
NCT01155869, a Phase 4 study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
Almost 200,000 veterans are homeless each night, about one-quarter to one-third of homeless adults in the U.S. Half need treatment for a substance use disorder, usually alcohol dependence, but sobriety is often required to access alcohol treatment and housing services. A monthly injection of depot naltrexone is efficacious in reducing alcohol use, but it is expensive and restricted in many VA Medical Centers. Oral naltrexone is more available but seldom used because of adherence problems that limit effectiveness. This open-label pilot study would compare the effect of depot versus oral naltrexone to help twenty homeless, alcohol-dependent veterans decrease their drinking, achieve sobriety and qualify for housing services. This study's findings could expand access to effective medication-assisted alcohol treatment in the VA, and thus help homeless veterans with alcohol problems improve their drinking, housing status, and appropriate use of health services.
Interventions
- DRUG Oral Naltrexone
- DRUG Depot naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155869
The ClinicalTrials.gov registry entry for NCT01155869 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral Naltrexone is the first listed.
NCT01155869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155869 about?
NCT01155869 is a clinical study titled "Pilot Study of Depot NTX in Homeless Veterans". Almost 200,000 veterans are homeless each night, about one-quarter to one-third of homeless adults in the U.S. Half need treatment for a substance use disorder, usually alcohol dependence, but sobriety is often required to access alcohol treatment and housing services. A monthly injection of depot n...
What is the current status of trial NCT01155869?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2010-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01155869?
The interventions under investigation include: Oral Naltrexone (DRUG), Depot naltrexone (DRUG).
Who is sponsoring clinical trial NCT01155869?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.